Pfizer reportedly approached Cellectis with a deal that could value it at about $1.64 billion, the Financial Times reported.» Read More
Small-cap stocks like regional banks look appealing as a Federal Reserve rate hike looms, a wealth manager said.
Despite numerous Wall Street proclamations that its demise is near, investors refuse to buy into the notion that the bond bull market is dead.
As inflation normalizes, investors should be exposed to companies that are boosting capital expenditures, Tom Lee tells CNBC.
In a strange coincidence, the charts for several top names are showing patterns that may be flashing a warning sign for stocks.
Big financials have been perking up lately and may be ready for an even greater run higher.
Options expert Stacey Gilbert explains why Facebook is trading at one of its highest discounts in the past year.
Earnings from companies are coming in much better than expected. The magnitude of this beat may surprise you.
Apple Watch won't supplant venerable luxury timepiece makers, but everyday fashion watch makers are in trouble, two former retail executives said.
Consumers seem to be spending money on cars, student loans, electronics and dining, but not on retail in general.
CNBC's Jim Cramer explains why a "no news is good news" rally may be coming.
Stocks could march into record territory in the week ahead—unless the economy starts to look too strong, or then again, too weak.
An expected dismal earnings season has become a positive, money-making one. Here are 5 ways to play it.
Some of the names on the move ahead of the open.
Lower revenues and a dip in credit expectations contributed to the decline in small business confidence, Wells Fargo said.
Here's the best research calls from top Wall Street firms Monday.
Have Internet stocks become dangerously overvalued? That’s what one striking chart may indicate.
“Mad Money” host Jim Cramer will be watching two reports like a hawk next week.
The chances of another sharp fall in the price of oil is rapidly receding, according to a notable European commodity analyst.
Five of the 50 companies on CNBC's 2014 disruptor list have gone public or been acquired—half the number that graduated from our 2013 list.
Traders are cheering data that suggest the Fed will put off a rate hike until September, economist Maury Harris says.